the "capital position" without a significant takeup from retail may be the similar again within 6 months. or maybe slightly longer. depending on how much it costs to fund the back pain trial.
but the companies "strategic position" would alter significantly with favourable outcome/s from the multiple conversations with the fda in the next quarter.
feedback on assays for bla
pathways for heart failure and heart disease
and ghvd adults protocol
- Forums
- ASX - By Stock
- MSB
- Ann: Information For Retail Shareholders
Ann: Information For Retail Shareholders, page-148
-
- There are more pages in this discussion • 394 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.14 |
Change
-0.010(0.87%) |
Mkt cap ! $1.295B |
Open | High | Low | Value | Volume |
$1.15 | $1.15 | $1.13 | $1.027M | 901.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 43817 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.14 | 57379 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 39479 | 1.135 |
27 | 89962 | 1.130 |
14 | 108387 | 1.125 |
15 | 296493 | 1.120 |
8 | 529412 | 1.115 |
Price($) | Vol. | No. |
---|---|---|
1.140 | 43984 | 3 |
1.145 | 79803 | 18 |
1.150 | 136047 | 10 |
1.155 | 23510 | 6 |
1.160 | 29090 | 3 |
Last trade - 12.01pm 22/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |